BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19750560)

  • 1. The effect of alcohol and tobacco consumption, and apolipoprotein E genotype, on the age of onset in Alzheimer's disease.
    Harwood DG; Kalechstein A; Barker WW; Strauman S; St George-Hyslop P; Iglesias C; Loewenstein D; Duara R
    Int J Geriatr Psychiatry; 2010 May; 25(5):511-8. PubMed ID: 19750560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E polymorphism and age of onset for Alzheimer's disease in a bi-ethnic sample.
    Harwood DG; Barker WW; Ownby RL; St George-Hyslop P; Mullan M; Duara R
    Int Psychogeriatr; 2004 Sep; 16(3):317-26. PubMed ID: 15559755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnoracial differences in the clinical characteristics of Alzheimer's disease at initial presentation at an urban Alzheimer's disease center.
    Livney MG; Clark CM; Karlawish JH; Cartmell S; Negrón M; Nuñez J; Xie SX; Entenza-Cabrera F; Vega IE; Arnold SE
    Am J Geriatr Psychiatry; 2011 May; 19(5):430-9. PubMed ID: 21522051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.
    Farrer LA; Cupples LA; Haines JL; Hyman B; Kukull WA; Mayeux R; Myers RH; Pericak-Vance MA; Risch N; van Duijn CM
    JAMA; 1997 Oct 22-29; 278(16):1349-56. PubMed ID: 9343467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein E polymorphism and age at onset of Alzheimer's disease in a quadriethnic sample.
    Kwon OD; Khaleeq A; Chan W; Pavlik VN; Doody RS
    Dement Geriatr Cogn Disord; 2010; 30(6):486-91. PubMed ID: 21252542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alzheimer's disease: interaction of apolipoprotein E genotype, family history of dementia, gender, education, ethnicity, and age of onset.
    Duara R; Barker WW; Lopez-Alberola R; Loewenstein DA; Grau LB; Gilchrist D; Sevush S; St George-Hyslop S
    Neurology; 1996 Jun; 46(6):1575-9. PubMed ID: 8649551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein E epsilon4 and age at onset of sporadic and familial Alzheimer disease in Caribbean Hispanics.
    Olarte L; Schupf N; Lee JH; Tang MX; Santana V; Williamson J; Maramreddy P; Tycko B; Mayeux R
    Arch Neurol; 2006 Nov; 63(11):1586-90. PubMed ID: 17101827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APOE ε4-TOMM40 '523 haplotypes and the risk of Alzheimer's disease in older Caucasian and African Americans.
    Yu L; Lutz MW; Wilson RS; Burns DK; Roses AD; Saunders AM; Yang J; Gaiteri C; De Jager PL; Barnes LL; Bennett DA
    PLoS One; 2017; 12(7):e0180356. PubMed ID: 28672022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
    Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
    BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The APOE-epsilon4 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics.
    Tang MX; Stern Y; Marder K; Bell K; Gurland B; Lantigua R; Andrews H; Feng L; Tycko B; Mayeux R
    JAMA; 1998 Mar; 279(10):751-5. PubMed ID: 9508150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ancestral origin of ApoE ε4 Alzheimer disease risk in Puerto Rican and African American populations.
    Rajabli F; Feliciano BE; Celis K; Hamilton-Nelson KL; Whitehead PL; Adams LD; Bussies PL; Manrique CP; Rodriguez A; Rodriguez V; Starks T; Byfield GE; Sierra Lopez CB; McCauley JL; Acosta H; Chinea A; Kunkle BW; Reitz C; Farrer LA; Schellenberg GD; Vardarajan BN; Vance JM; Cuccaro ML; Martin ER; Haines JL; Byrd GS; Beecham GW; Pericak-Vance MA
    PLoS Genet; 2018 Dec; 14(12):e1007791. PubMed ID: 30517106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative risk of Alzheimer disease and age-at-onset distributions, based on APOE genotypes among elderly African Americans, Caucasians, and Hispanics in New York City.
    Tang MX; Maestre G; Tsai WY; Liu XH; Feng L; Chung WY; Chun M; Schofield P; Stern Y; Tycko B; Mayeux R
    Am J Hum Genet; 1996 Mar; 58(3):574-84. PubMed ID: 8644717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Race-Ethnicity and History of Traumatic Brain Injury With Age at Onset of Alzheimer's Disease.
    Bailey KC; Burmaster SA; Schaffert J; LoBue C; Vela D; Rossetti H; Cullum CM
    J Neuropsychiatry Clin Neurosci; 2020; 32(3):280-285. PubMed ID: 31619118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.
    Langbaum JB; Chen K; Caselli RJ; Lee W; Reschke C; Bandy D; Alexander GE; Burns CM; Kaszniak AW; Reeder SA; Corneveaux JJ; Allen AN; Pruzin J; Huentelman MJ; Fleisher AS; Reiman EM
    Arch Neurol; 2010 Apr; 67(4):462-8. PubMed ID: 20385913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is ApoE epsilon4 associated with cognitive functioning in African Americans diagnosed with Alzheimer Disease? An exploratory study.
    Mount DL; Ashley AV; Lah JJ; Levey AI; Goldstein FC
    South Med J; 2009 Sep; 102(9):890-3. PubMed ID: 19668025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein E polymorphism and cognitive impairment in a bi-ethnic community-dwelling elderly sample.
    Harwood DG; Barker WW; Ownby RL; Mullan M; Duara R
    Alzheimer Dis Assoc Disord; 2002; 16(1):8-14. PubMed ID: 11882744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
    Saddiki H; Fayosse A; Cognat E; Sabia S; Engelborghs S; Wallon D; Alexopoulos P; Blennow K; Zetterberg H; Parnetti L; Zerr I; Hermann P; Gabelle A; Boada M; Orellana A; de Rojas I; Lilamand M; Bjerke M; Van Broeckhoven C; Farotti L; Salvadori N; Diehl-Schmid J; Grimmer T; Hourregue C; Dugravot A; Nicolas G; Laplanche JL; Lehmann S; Bouaziz-Amar E; ; Hugon J; Tzourio C; Singh-Manoux A; Paquet C; Dumurgier J
    PLoS Med; 2020 Aug; 17(8):e1003289. PubMed ID: 32817639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein E genotypes in hospitalized elderly patients with vascular dementia.
    Orsitto G; Seripa D; Panza F; Franceschi M; Cascavilla L; Placentino G; Matera MG; Paris F; Capurso C; Solfrizzi V; Dallapiccola B; Pilotto A
    Dement Geriatr Cogn Disord; 2007; 23(5):327-33. PubMed ID: 17374951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between APOC1 polymorphism and Alzheimer's disease: a case-control study and meta-analysis.
    Zhou Q; Zhao F; Lv ZP; Zheng CG; Zheng WD; Sun L; Wang NN; Pang S; de Andrade FM; Fu M; He XH; Hui J; Jiang W; Yang CY; Shi XH; Zhu XQ; Pang GF; Yang YG; Xie HQ; Zhang WD; Hu CY; Yang Z
    PLoS One; 2014; 9(1):e87017. PubMed ID: 24498013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.